A multidisciplinary group will characterize growth regulation in human colon neoplasms to identify growth regulatory targets for development of anticolon cancer therapeutic agents. The in vitro model system will consist of the types of cells found in normal colon; hyperplastic polyps, adenomatous polyps and carcinomas. Comparative analysis of the biological characteristics of each type of cell will be made and include tumorigenicity, ability to grow with anchorage independence, metastatic capability and analysis of differentiation markers. A profile of expression of growth regulatory mechanisms will be established for each growth phenotype. This profile will provide for the characterization of the dependence of the growth of cellular phenotypes on specific autocrine growth factors, exogenous growth factors and oncogenes. Cellular phenotype specific interrelationships among these three types of molecules will also be characterized. These characterizations will identify autocrine factors which if uncoupled (either by antibodies or analogues) could lead to a significant change in the dependent cell's biological characteristics toward a more benign phenotype or perhaps cell death. Uncoupling of synergistic inter- relationships among these types of molecules could also produce the same result. It will be determined whether modulation of the growth regulatory phenotype associated with a cellular phenotype will also result in the modulation of the biological properties associated with the phenotype. This will be accomplished by developing appropriate transfection vectors for the overexpression of growth regulatory associated autocrine factors and oncogenes in benign cells. Successfully transfected cells will be tested for alterations in biological and growth regulatory phenotypes. Some oncogenes have been associated with the expression of differentiated functions in colon and other systems. These will also be tested in transfection systems to determine whether their overexpression will modulate malignant phenotypes to more benign states. It will also be determined whether a series of putative differentiation or inhibitory agents can affect the biological and growth regulatory phenotypes in a similar manner. Of particular interest will be the effects of differentiation promoting transfections and the inhibitory agents on the expression of growth regulatory molecules and their relationships since the development of agents to mimic these effects could allow for effective therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA045967-05
Application #
3549015
Study Section
Special Emphasis Panel (SRC (54))
Project Start
1987-09-03
Project End
1992-05-31
Budget Start
1991-06-01
Budget End
1992-05-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Kitamura, H; Cho, M; Lee, B H et al. (1996) Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations. Eur J Cancer 32A:1788-96
Ho, S B; Yan, P S; Dahiya, R et al. (1994) Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. J Cell Physiol 160:213-26
Yeoman, L C (1993) An autocrine model for cell- and matrix-associated fibroblast growth factor. Oncol Res 5:489-99
Ziober, B L; Willson, J K; Hymphrey, L E et al. (1993) Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells. J Biol Chem 268:691-8
Lynch, M J; Pelosi, L; Carboni, J M et al. (1993) Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Cancer Res 53:4041-7
Niv, Y; Byrd, J C; Ho, S B et al. (1992) Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer 50:147-52
Yeoman, L C; Danels, Y J; Lynch, M J (1992) Lipofectin enhances cellular uptake of antisense DNA while inhibiting tumor cell growth. Antisense Res Dev 2:51-9
Schwartz, B; Bresalier, R S; Kim, Y S (1992) The role of mucin in colon-cancer metastasis. Int J Cancer 52:60-5
Taylor, C W; Kim, Y S; Childress-Fields, K E et al. (1992) Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines. Cancer Lett 62:95-105
Wu, S P; Theodorescu, D; Kerbel, R S et al. (1992) TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 116:187-96

Showing the most recent 10 out of 35 publications